Cargando…
Digoxin–mortality: randomized vs. observational comparison in the DIG trial
AIMS: The Digitalis Investigation Group (DIG) trial, the only large randomized trial of digoxin in heart failure, reported a neutral effect on mortality and a significant reduction in heart failure hospitalizations. Recent observational studies reported increased mortality with digoxin treatment. We...
Autores principales: | Aguirre Dávila, Lukas, Weber, Kristina, Bavendiek, Udo, Bauersachs, Johann, Wittes, Janet, Yusuf, Salim, Koch, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801940/ https://www.ncbi.nlm.nih.gov/pubmed/31211324 http://dx.doi.org/10.1093/eurheartj/ehz395 |
Ejemplares similares
-
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017) -
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
por: Bavendiek, Udo, et al.
Publicado: (2019) -
Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis
por: Kattih, Badder, et al.
Publicado: (2019) -
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder
por: Neuser, Jonas, et al.
Publicado: (2016) -
Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015)